Breaking News

Albumedix Completes Commercial-Scale Mfg. Facility Expansion

Will service increasing demand for products and technologies for cell and gene therapies, vaccines, diagnostics, protein and peptide therapeutics.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Albumedix Ltd., a company specializing in recombinant human albumin for advanced therapies, completed the expansion of its commercial-scale manufacturing facility, alongside with the establishment of a new Technology Centre equipped with state-of-the-art labs at its UK-based campus in Nottingham.   “Biopharmaceuticals has for a long time been a truly innovative corner of our industry; over the past 5-10 years we have experienced the incredible speed by which cellular and gene therapies h...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters